These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32400862)

  • 1. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma.
    Xu X; Dai Y; Feng L; Zhang H; Hu Y; Xu L; Zhu X; Jiang Y
    Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):527-535. PubMed ID: 32400862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voltage-gated sodium channel Nav1.5 promotes proliferation, migration and invasion of oral squamous cell carcinoma.
    Zhang J; Mao W; Dai Y; Qian C; Dong Y; Chen Z; Meng L; Jiang Z; Huang T; Hu J; Luo P; Korner H; Jiang Y; Ying S
    Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):562-570. PubMed ID: 31139826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt/β-catenin signaling pathway.
    Shao TR; Zheng ZN; Chen YC; Wu QQ; Huang GZ; Li F; Zeng WS; Lv XZ
    Life Sci; 2019 Dec; 239():117087. PubMed ID: 31759044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RELA promotes the progression of oral squamous cell carcinoma via TFAP2A-Wnt/β-catenin signaling.
    Yang K; Zhao J; Liu S; Man S
    Mol Carcinog; 2023 May; 62(5):641-651. PubMed ID: 36789977
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
    [No Abstract]   [Full Text] [Related]  

  • 9. The Antihelminthic Niclosamide Inhibits Cancer Stemness, Extracellular Matrix Remodeling, and Metastasis through Dysregulation of the Nuclear β-catenin/c-Myc axis in OSCC.
    Wang LH; Xu M; Fu LQ; Chen XY; Yang F
    Sci Rep; 2018 Aug; 8(1):12776. PubMed ID: 30143678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MINCR activates Wnt/β-catenin signals to promote cell proliferation and migration in oral squamous cell carcinoma.
    Lyu Q; Jin L; Yang X; Zhang F
    Pathol Res Pract; 2019 May; 215(5):924-930. PubMed ID: 30777615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCAPD2 promotes the malignant progression of oral squamous cell carcinoma via the Wnt/β-catenin pathway.
    Ma P; Yu H; Zhu M; Liu L; Cheng L; Han Z; Jin W
    Cell Cycle; 2024 Mar; 23(5):588-601. PubMed ID: 38743408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma.
    Li L; Liu HC; Wang C; Liu X; Hu FC; Xie N; Lü L; Chen X; Huang HZ
    Biomed Res Int; 2016; 2016():5378567. PubMed ID: 27529071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
    Tong S; Wang X; Guo X; Lu Z
    J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
    Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
    Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
    Hou Z; Wu C; Tang J; Liu S; Li L
    Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
    Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
    BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small nucleolar RNA host gene 3 facilitates cell proliferation and migration in oral squamous cell carcinoma via targeting nuclear transcription factor Y subunit gamma.
    Liu Z; Tao H
    J Cell Biochem; 2020 Mar; 121(3):2150-2158. PubMed ID: 31762107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.